Semaglutide reduces body weight to a greater extent in females; yields similar improvements in heart failure-related symptoms in both sexes

Two randomized controlled trials show reduction in AHI; significant improvements seen in all secondary end points

Within-species phylogenetic diversity identified for strains of 27 species that explain inter-individual differences in type 2 diabetes risk

Benefits include improved glycemic outcomes and weight loss at 16 weeks in the short term compared with metformin or empagliflozin

By Ernie Mundell HealthDay ReporterMONDAY, June 24, 2024 (HealthDay News) — The U.S. Supreme Court announced Monday that it would hear a case on a Tennessee law that bans transgender minors from receiving certain medical treatments in that state.The banned treatments include puberty-blocking drugs or hormonal therapies.It’s the first time …

Significant improvement seen in endocrine symptom subscale score, hot flash score, FACT-Breast total score

Glucose lowering is greater when metformin is given before rather than with enteral glucose; this is also linked to greater GLP-1 response

Beneficial effect on glucose hemostasis seen for accumulation of more MVPA in the evening for sedentary adults

By Beth Gilbert HealthDay ReporterThe annual meeting of the Endocrine Society (ENDO 2024) was held from June 1 to 4 in Boston, attracting approximately 7,000 participants, including clinicians, academicians, allied health professionals, and others interested in endocrine and metabolic disorders. The conference highlighted recent advances in the diagnosis and management …

Little to no increased risk for nonlive birth seen among women continuing metformin and adding insulin versus switching to insulin monotherapy